Amid Hydroxychloroquine Uproar, Real Studies of Drug Are Suffering (New York Times, quotes Christine Johnston)

President Trump’s enthusiastic embrace of a malaria drug that he now says he takes daily — and the resulting uproar in the news media — appears to be interfering with legitimate scientific research into whether the medicine might work to prevent coronavirus infection or treat the disease in its early stages.

3 Steps to Help Prevent Another Animal-to-Human Virus Pandemic (Seattle Times, co-written by Peter Rabinowitz)

By Peter Rabinowitz and Greg Gray

Governments and individuals are taking unprecedented, often very austere actions to control the ongoing spread of the pandemic coronavirus (SARS-CoV-2). However, they are neglecting an extremely important question that could cause the loss of millions of more lives — how do we prevent the next zoonotic respiratory virus pandemic?

We have not yet identified the source of this virus. What if a new version emerges from the original animal source to cause a second wave of this pandemic?

Coronavirus: Our Experts in the News

The following links are a collection of news stories about the coronavirus that either quote, include, or were written by Department of Global Health faculty and staff. This includes video interviews with local and national media outlets, as well as written stories detailing DGH's research and innovation in fighting COVID-19. 

Also see UW School of Public Health's web pages on Coronavirus Response, Resources and News

UW to Lead National Study of Drug Promoted by President Trump to Fight Coronavirus (Seattle Times, Includes Ruanne Barnabas)

Researchers at the University of Washington on Friday announced a major new study of the malaria drug President Donald Trump has praised as a possible, low-cost cure for COVID-19.

The clinical trial is one of dozens around the world aimed at providing definitive evidence about the effectiveness of hydroxychloroquine, either alone or in combination with the antibiotic azithromycin, against the novel coronavirus.

Why There Isn’t a One-Size-Fits-All Plan for States to Reopen Their Economies (The Conversation, Q&A with Hilary Godwin)

In this Q&A, Hilary Godwin, dean of the University of Washington School of Public Health, explains why it makes sense for groups of states, such as Washington, Oregon and California, to coordinate their plans.

Governors are walking a tightrope as they try to figure out how to safely ease off social distancing restrictions and restart their economies without triggering a new surge in coronavirus cases.

Pages